Chief Development Officer

Lindus
Hybrid

About The Position

As Chief Development Officer, you will own development across the Lindus Therapeutics portfolio, focusing on in-licensed assets with trials starting in 2027. You will report to the CEO, lead the Lindus Tx team, manage the VP Corp Dev and asset leads, and join the company executive team. Your role is to be the senior development voice on each asset, determining how it can be advanced quickly and capital-efficiently to a proof-of-concept readout that a specialty pharma or strategic buyer will pay for. You will set development strategy, design studies, and build the regulatory and CMC path for each asset. This is a hands-on role where you will assemble and direct a lean development organization of fractional and consultant experts, with a development lead on each program reporting to you. Your ability to find the right people and negotiate terms is as important as the development science. The decision on whether an asset is developable and worth pursuing rests with you.

Requirements

  • Senior drug development leader with experience taking multiple assets through clinical development, across more than one therapeutic area, from FIH and into Phase 2 or Phase 3.
  • Experience with regulatory strategy and FDA interactions, ideally EMA as well, with full visibility on FDA and EMA data package requirements.
  • Experience with in-licensed and partnered assets, and a range of therapeutic areas.
  • Experience picking up an asset through business development and building a plan for a future partner or acquirer.
  • Experience sitting on at least one side of a licensing or M&A deal.
  • Ability to design around the exit, understanding what a partner needs at proof-of-concept and building the program without gold-plating.
  • Experience overseeing a portfolio of assets and comfortable ruthlessly prioritizing between programs.
  • Ability to run lean in a biotech setting, delivering strong data on tight budgets and timelines.
  • Preference for running development through a small core team and a network of specialists over a large internal department.
  • A network to draw on for regulatory, CMC, pharmacology, and clinical capabilities.
  • Comfortable with AI tools across research, planning, and analysis, with a clear sense of where they help and where human judgment is needed.

Nice To Haves

  • Experience taking a drug all the way to approval is a plus.

Responsibilities

  • Owning development strategy across the LTx portfolio, and deciding how each asset reaches a value-generating proof-of-concept readout quickly and efficiently.
  • Designing proof-of-concept studies, run on our clinical trial platform, and building the regulatory and CMC plans behind them.
  • Leading scientific, clinical and regulatory diligence on shortlisted assets alongside the deal team and external experts, and making the developability call.
  • Building and directing a virtual development organisation: recruiting and managing fractional and consultant CMC, regulatory, pharmacology and clinical talent, and the development lead on each programme.
  • Designing each programme backward from the exit, so the data and CMC package is built for what a strategic or specialty pharma buyer will pay for.
  • Partnering with the VP Corporate Development on asset evaluation, deal structuring and negotiation, providing the development view into diligence.
  • Managing interactions with the FDA, EMA and other regulators across the portfolio.
  • Representing LTx’s development thesis with investors, partners and the board.

Benefits

  • Competitive salary plus meaningful equity
  • $2,000 annual Learning & Development budget
  • 39 days annual leave (27 days PTO + 11 federal holidays + 1 James Lind Day)
  • $800 monthly employer contribution toward insurance for US team members (via TriNet PEO)
  • $40 monthly wellness allowance
  • Access to gym and retail discounts through Happl
  • Regular company events and team gatherings (both virtual and in-person)
  • Charity partnerships and volunteering opportunities with Forward Trust
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service